Automated insulin reduces hypoglycaemia in elderly, enabling safer diabetes management for seniors- read to learn more.

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes CATT1 Phase 3 trial expected to ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its revolutionary Omnipod 5 ...

Hybrid closed-loop insulin delivery lowers risk for hypoglycemic coma and increases rate of ketoacidosis for young people with T1D.

Growth hormone injections deliver a synthetic growth hormone to the body to treat hormone deficiencies and other health ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes CATT1 Phase 3 trial expected to resume following submission of protocol amendment shortening the overall durati ...

Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...

Insulet shows bullish trends with strong growth, favorable Wall Street ratings, and a 3.2:1 reward-risk ratio. Read more on ...

Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of ...

Family history increases diabetes risk, but these proven strategies can help you overcome genetic predisposition and prevent ...

The genesis of Alcoholics Anonymous began in 1935 in Akron, Ohio, when two men were looking for a successful way to end their ...